Stock Screener App

Frei -

Installieren

1.221

3.10% -0.039

after-market

Handel nachbörslich: 1.22 -0.001 -0.08%

Bionexus Gene Lab Corp (BGLC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	233.40% 0.0762	0.0228	0.4838	2.5438	2.2603
Cost Of Revenue	167.32% 0.0632	0.0236	0.4877	2.1661	1.8922
Gross Profit	1,743% 0.013	-0.00079	-0.00398	0.3777	0.368
Operating Expenses	30.30% 0.4164	0.5974	1.0523	1.188	1.1888
Operating Income/Loss	47.75% -0.2824	-0.5405	-1.0328	-0.7025	-0.6113
Income/Loss From Continuing Operations Before Tax	47.30% -0.2865	-0.5436	-1.0361	-0.709	-0.6162
Income Tax Expense/Benefit, Current	-	-	-	-	-
Income Tax Expense/Benefit, Deferred	-	-	-	-	-
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	47.30% -0.2865	-0.5436	-1.0361	-0.709	-0.6162
Diluted Average Shares	0.00% 2.4173	2.4173	-	1.7966	1.7966
Diluted Earnings Per Share	47.56% -0.118	-0.225	-	-0.395	-0.343

SNES

$0.6992

9.25%

CNEY

$0.3992

1.09%

YMAT

$1.51

4.43%

BON

$1.13

0.00%

LOOP

$0.3722

8.83%

CITR

$3.00

14.50%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters